Google News – Pharmaceuticals External News
Life Sciences & Pharma Articles
Google News – Clinical Trials External News
Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE) - Intellia Therapeutics
Industry News External News
After Cigna dropped GLP-1 coverage, employees started a petition
Google News – Pharmaceuticals External News
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer - GlobeNewswire
Google News – Pharmaceuticals External News
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Google News – Pharmaceuticals External News
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq - GlobeNewswire
Google News – Oncology External News
Medicus Pharma shifts focus to precision oncology with CD228V - Investing.com
Google News – Clinical Trials External News
Multiple Sclerosis Drug Patch Moves Closer to Clinical Trials - Technology Networks
Google News – Oncology External News
Medicus Pharma Advances Transformation Into A Precision Oncology-Led Biotechnology Company - tradingview.com
Google News – Oncology External News
Medicus Pharma shifts focus to precision oncology with CD228V By Investing.com - Investing.com UK
Google News – Oncology External News
Medicus Pharma Ltd. Repositions as Precision Oncology-Led Biotech, Prioritizes CD228V, SkinJect and Teverelix Programs - Quiver Quantitative
Google News – Biopharma External News
A 10% slice of Zenas BioPharma (NASDAQ: ZBIO) sits with one investment group - Stock Titan
Google News – Oncology External News
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company - Yahoo Finance
Google News – Clinical Trials External News
Oncologists say newly approved pancreatic cancer drug is a breakthrough for treatment - healthcare-brew.com
Google News – Biopharma External News